Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000181747 | SCV000234050 | benign | not specified | 2013-03-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000232365 | SCV000283984 | benign | Long QT syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000232365 | SCV000467503 | likely benign | Long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000181747 | SCV000613855 | benign | not specified | 2017-07-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001842817 | SCV000902994 | benign | Cardiac arrhythmia | 2018-03-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001812169 | SCV001159573 | benign | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000181747 | SCV001364006 | benign | not specified | 2019-09-03 | criteria provided, single submitter | clinical testing | Variant summary: KCNH2 c.3331-9_3331-8delGT alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0037 in 161778 control chromosomes, predominantly at a frequency of 0.055 within the African or African-American subpopulation in the gnomAD database, including 19 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 550 fold of the estimated maximal expected allele frequency for a pathogenic variant in KCNH2 causing Arrhythmia phenotype (0.0001), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. Four ClinVar submitters (evaluation after 2014) cite the variant as benign (3x) and once as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Fulgent Genetics, |
RCV002500532 | SCV002806383 | likely benign | Short QT syndrome type 1; Long QT syndrome 2 | 2022-02-15 | criteria provided, single submitter | clinical testing |